$CTS

O'SULLIVAN KIERAN M sold $8.5M of CTS

O'SULLIVAN KIERAN M (President & CEO) sold 130,000 shares of CTS CORP (CTS) at an average of $65.27 ($63.31–$66.67, $8.48M total) across 3 trades over 2026-06-01 to 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'SULLIVAN KIERAN M
Published Jun 3, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CTS
Bearish
medium confidence
Mentioned
$CTS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSBearishLow
01

Why it matters

The CEO's $8.5M sale reduces his ownership stake, which could be interpreted by the market as a lack of confidence, potentially prompting short‑term price weakness.

02

Market read

Primary insider sale news; relevant for traders monitoring CTS stock for short‑term moves.

03

What to watch

Potential upcoming corporate actions or financing needs that prompted the pre‑arranged sale.

Relevance 5/10Novelty 5/10Timing: today

Background

SEC Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$CTSBearishMedium confidence
Context

President & CEO Kieran O'Sullivan sold $8.5M of CTS shares via a 10b5‑1 plan, reducing his stake to 307,693 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $8.5M open‑market sale by the CEO is material for a mid‑cap stock and can prompt sell‑offs, especially when executed over three days.

Market effects

Minimal; the sale is company‑specific and does not affect the broader sector.

None; the filing is U.S.‑focused.

Low; only relevant to CTS investors.

Counterpoint

The sale may be purely procedural under the 10b5‑1 plan and not indicative of negative outlook.

Key entities

  • CTS Corp

    Mid‑cap industrial services firm listed on NYSE under ticker CTS.

  • Kieran O'Sullivan

    President & CEO of CTS Corp, insider reporting the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTSMedAI 8/10

CTS Q3 Earnings Call Highlights

CTS acquired Millar for $50M, expecting $30M annual revenue and EPS accretion by H2 2027. Millar's medical and sensing capabilities complement CTS's portfolio. Q3 saw mixed segment performance, with aerospace/defense up 30% QoQ. CTS raised 2026 guidance to $580M-$590M sales and $2.78-$2.88 EPS, citing diversified demand.

$CTSHighAI 8/10

CTS (CTS) Q3 2026 Earnings Call Transcript

CTS reported Q3 2026 earnings with record gross margin at 42.2% and adjusted EPS at $0.77. The company acquired Millar, expecting $30M annual revenue, and raised full-year guidance to $580M-$590M sales and $2.78-$2.88 adjusted EPS. Medical, industrial, and transportation markets showed growth, with medical up 21% YoY. The acquisition is expected to be accretive in H2 2027.

$CTSHighAI 8/10

CTS Q3 2026 slides: record margins fuel guidance raise

CTS Corporation (NYSE:CTS) reported Q3 2026 earnings of $0.77 per share on revenue of $149.6M, beating estimates. Adjusted gross margin hit a record 42.2%. The company raised full-year guidance, citing strong demand and diversification. Shares rose 5.42% premarket. CTS acquired Millar to expand into medical and industrial sensing.

$CTSHigh

CTS (CTS) stock is up, what you need to know

CTS Corporation (NYSE: CTS) shares rose 4.5% after reporting Q3 2026 results with revenue of $149.6M, net income of $17.8M, and EPS of $0.77, all above estimates. The company raised its full-year revenue and earnings guidance, exceeding consensus forecasts. The stock has gained 29.1% year-to-date but remains 17.1% below its 52-week high.

$CTSHigh

Why is CTS stock surging today?

CTS stock surged 4.6% in pre-market trading after reporting Q3 earnings that exceeded expectations. Adjusted EPS was $0.77, up from the $0.65 consensus, and sales rose 5% YoY to $149.6M. The company raised its 2026 guidance for EPS and sales, citing strong demand and a recent acquisition of Millar Holdings for $50M.